BioSpace News Archive

Pfizer’s First Quarter Marked by Strong Pipeline, Jump in Profit, but Lower Revenue than Expected

Overall, Pfizer posted a good first quarter, with sales slightly higher and a 14 percent increase in profits due to lower restructuring costs and a significantly lower tax rate. However, revenue was below Wall Street expectations.

May 1, 2018

·

2 min read

·

Mark Terry

Genetown

Digital Health Movement Continues to Grow, as Do Concerns Over Privacy

Getting patients to adhere to long-term treatments can be difficult. There are a number of new therapies that will monitor whether or not patients are sticking to their regimen.

May 1, 2018

·

4 min read

·

Alex Keown

Career Advice

5 Important Questions to Ask Before You Accept the Job Offer

It may not feel like it when you’re preparing for interviews, putting your application materials together, and in general trying to become the best possible job candidate… but you’re also evaluating potential new employers to see if their organization is the right fit for you.

May 1, 2018

·

3 min read

The Power of a Good Leadership Philosophy: Who Needs One and What Should It Say

A personal leadership philosophy does more than just describe someone’s unique management style. It serves a very specific purpose and lays out the high-level guiding principles leaders use to run successful departments, teams or organizations.

May 1, 2018

·

3 min read

Business

Gilead Sciences Announces Second Quarter 2018 Dividend

Gilead Sciences, Inc. announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the second quarter of 2018.

May 1, 2018

·

1 min read

Business

Intersect ENT Reports First Quarter 2018 Results

Intersect ENT, Inc. reported financial results for the first quarter ended March 31, 2018.

May 1, 2018

·

6 min read

Genetown

Alnylam to Webcast Presentations at Several Upcoming May Investor Conferences

Alnylam Pharmaceuticals, Inc. announced that management will present company overviews at the following conferences:

May 1, 2018

·

1 min read

Business

NeoImmuneTech Announces a Clinical Trial Collaboration with a Global Leading Pharmaceutical Company to Evaluate HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers

NeoImmuneTech have entered into an agreement with Roche to enable studies of a combination treatment in three advanced high-risk skin cancer types.

May 1, 2018

·

4 min read

BioMidwest

Diplomat to Participate in 43rd Annual Deutsche Bank Health Care Conference

Diplomat Pharmacy, Inc. executives will attend the 43rd Annual Deutsche Bank Health Care Conference in Boston.

May 1, 2018

·

1 min read

Business

Gilead Sciences Announces First Quarter 2018 Financial Results

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the first quarter ended March 31, 2018.

May 1, 2018

·

23 min read